跳至主要内容
临床试验/ISRCTN68849312
ISRCTN68849312已完成不适用

Reversal of cerebrovascular endothelial dysfunction in diabetes: the effect of allopurinol upon cerebrovascular nitric oxide bioavailability

Greater Glasgow NHS Board/Glasgow University (UK)0 个研究点目标入组 24 人开始时间: 2005年11月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Type II diabetes less than 5 years duration, treated with diet, metformin thiazolidinediones or a combination
  • 2. Aged greater than 40 years
  • 3. Normal full Bruce protocol exercise treadmill testing (ETT)
  • 4. Favourable temporal bony window
  • 5. HbA1c less than 9%
  • 6. Cholesterol less than 7.5 mmol/l

排除标准

  • 1. Greater than 70% Internal carotid artery stenosis
  • 2. Known coronary artery disease
  • 3. Other significant comorbidity
  • 4. Contraindication to allopurinol
  • 5. Concurrent therapy with azathioprine or 6-mercaptopurine
  • 6. Insulin or sulphonylurea treatment
  • 7. Serum creatinine greater than 250 µmol/l

研究者

发起方
Greater Glasgow NHS Board/Glasgow University (UK)

相似试验